Aptevo Financial Statements From 2010 to 2026

Aptevo Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 13 K 12.4 K 6.3 K Pretty Stable Total Assets 13.3 M 14 M 73.8 M Slightly volatile Other Current Liabilities 2.7 M 2.8 M 8 M Pretty Stable Total Current Liabilities 5.3 M 5.6 M 17.4 M Slightly volatile Total Stockholder Equity 4.1 M 4.3 M 46.9 M Slightly volatile Other Liabilities 14.7 M 14 M 9.6 M Slightly volatile Net Tangible Assets 18.4 M 16.2 M 20.9 M Pretty Stable Property Plant And Equipment Net 5.9 M 5.7 M 4.9 M Slightly volatile Accounts Payable 2.6 M 2.7 M 7.9 M Slightly volatile Cash 9.5 M 10 M 13.8 M Slightly volatile Non Current Assets Total 4.2 M 4.4 M 34.7 M Slightly volatile Cash And Short Term Investments 7.5 M 7.8 M 20.6 M Pretty Stable Net Receivables 4.5 M 2.2 M 7.2 M Slightly volatile Liabilities And Stockholders Equity 13.3 M 14 M 73.8 M Slightly volatile Non Current Liabilities Total 4 M 4.2 M 9.5 M Very volatile Inventory 1.3 M 1.4 M 8.2 M Slightly volatile Other Current Assets 1.7 M 1.8 M 4.7 M Slightly volatile Total Liabilities 9.3 M 9.8 M 26.9 M Slightly volatile Property Plant And Equipment Gross 22.8 M 21.7 M 9.1 M Slightly volatile Total Current Assets 9.1 M 9.6 M 39 M Slightly volatile Short Term Debt 1.7 M 1.8 M 6.4 M Slightly volatile Intangible Assets 3.8 M 4 M 25.1 M Slightly volatile Common Stock 71.8 K 75.6 K 97.5 M Slightly volatile Property Plant Equipment 5.9 M 7.8 M 5.2 M Slightly volatile Other Assets 58.1 K 61.2 K 17.2 M Slightly volatile Short and Long Term Debt Total 4 M 4.2 M 15.4 M Slightly volatile Long Term Debt 1.2 M 1.3 M 12.6 M Slightly volatile Common Stock Total Equity 34.3 K 52.9 K 32.2 K Slightly volatile Short Term Investments 70.5 M 84.7 M 62.3 M Slightly volatile Long Term Debt Total 19.6 M 22.2 M 18.9 M Slightly volatile Capital Surpluse 177.3 M 206.6 M 166.7 M Slightly volatile Short and Long Term Debt 1.7 M 1.8 M 11.6 M Slightly volatile Non Current Liabilities Other 18.8 M 17.9 M 7.2 M Slightly volatile Net Invested Capital 4.1 M 4.3 M 58.5 M Slightly volatile Capital Stock 55.6 K 96.6 K 40.6 K Slightly volatile Capital Lease Obligations 4.2 M 5.3 M 3.7 M Slightly volatile
Aptevo Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 301 K 316.8 K 1.3 M Slightly volatile Selling General Administrative 18.3 M 9.2 M 20.5 M Slightly volatile Other Operating Expenses 21 M 22.1 M 51.6 M Slightly volatile Research Development 21.6 M 12.9 M 27.8 M Slightly volatile Cost Of Revenue 301 K 316.8 K 17.7 M Slightly volatile Total Operating Expenses 38.6 M 21.8 M 47 M Slightly volatile Discontinued Operations 866.1 K 911.7 K 7 M Slightly volatile Non Recurring 56.8 M 63.9 M 69.8 M Slightly volatile Extraordinary Items 3.6 M 3.8 M 7.6 M Pretty Stable Reconciled Depreciation 301 K 316.8 K 2 M Slightly volatile
Aptevo Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 1.6 M 962.1 K 1.7 M Very volatile Depreciation 301 K 316.8 K 1.4 M Pretty Stable End Period Cash Flow 9.5 M 10 M 14.9 M Slightly volatile Begin Period Cash Flow 24.4 M 19.4 M 16.7 M Slightly volatile Issuance Of Capital Stock 7.6 M 9 M 15.1 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 4.15 4.37 20.0103 Slightly volatile PTB Ratio 0.27 0.29 6.7278 Pretty Stable Days Sales Outstanding 277 264 162 Slightly volatile Book Value Per Share 6.8 K 7.1 K 2 M Slightly volatile Stock Based Compensation To Revenue 0.88 0.67 1.5918 Slightly volatile Capex To Depreciation 0.0352 0.037 0.5693 Slightly volatile PB Ratio 0.27 0.29 6.7278 Pretty Stable Inventory Turnover 0.31 0.33 1.3569 Pretty Stable Days Of Inventory On Hand 947 902 619 Slightly volatile Payables Turnover 0.13 0.1153 0.8066 Slightly volatile Sales General And Administrative To Revenue 2.37 4.01 3.3268 Pretty Stable Research And Ddevelopement To Revenue 6.27 6.6 55.4215 Slightly volatile Capex To Revenue 0.0102 0.0107 1.438 Slightly volatile Cash Per Share 12.4 K 13.1 K 5 M Slightly volatile Days Payables Outstanding 3 K 2.8 K 1.6 K Slightly volatile Intangibles To Total Assets 0.0904 0.0952 0.2797 Slightly volatile Current Ratio 2.85 1.97 2.4511 Very volatile Tangible Book Value Per Share 6.8 K 7.1 K 2 M Slightly volatile Receivables Turnover 1.36 1.43 9.5784 Pretty Stable Shareholders Equity Per Share 6.8 K 7.1 K 2 M Slightly volatile Debt To Equity 0.83 0.88 1.4366 Pretty Stable Capex Per Share 3.6 K 3.8 K 16.1 K Very volatile Revenue Per Share 390.9 K 411.5 K 682.6 K Slightly volatile Interest Debt Per Share 6.6 K 6.9 K 3.3 M Slightly volatile Debt To Assets 0.24 0.27 0.2585 Slightly volatile Graham Number 5.2 M 5.9 M 6.4 M Slightly volatile Operating Cycle 369 337 375 Slightly volatile Price Book Value Ratio 0.27 0.29 6.7278 Pretty Stable Days Of Payables Outstanding 3 K 2.8 K 1.6 K Slightly volatile Effective Tax Rate 0.39 0.38 0.2512 Slightly volatile Company Equity Multiplier 5.06 2.95 4.8577 Pretty Stable Long Term Debt To Capitalization 0.0641 0.0674 0.2717 Pretty Stable Total Debt To Capitalization 0.38 0.44 0.3898 Slightly volatile Debt Equity Ratio 0.83 0.88 1.4366 Pretty Stable Quick Ratio 1.88 1.55 2.0094 Pretty Stable Cash Ratio 1.0 1.26 0.9842 Slightly volatile Days Of Inventory Outstanding 947 902 619 Slightly volatile Days Of Sales Outstanding 277 264 162 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.12 1.15 1.0333 Slightly volatile Price To Book Ratio 0.27 0.29 6.7278 Pretty Stable Fixed Asset Turnover 0.5 0.53 5.8512 Slightly volatile Debt Ratio 0.24 0.27 0.2585 Slightly volatile Price Sales Ratio 4.15 4.37 20.0103 Slightly volatile Asset Turnover 0.0994 0.1 0.2303 Slightly volatile Price Fair Value 0.27 0.29 6.7278 Pretty Stable
Aptevo Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 2.3 M 2.4 M 146.8 M Slightly volatile

Aptevo Fundamental Market Drivers

Aptevo Upcoming Events

About Aptevo Therapeutics Financial Statements

Pair Trading with Aptevo Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptevo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will appreciate offsetting losses from the drop in the long position's value.When determining whether Aptevo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptevo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptevo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptevo Therapeutics Stock:

How To Invest In Aptevo Details

Is Aptevo Stock a good investment? Details

What is Aptevo Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details